Ten-year follow-up on efficacy, immunogenicity and safety of two doses of a combined measles-mumps-rubella-varicella vaccine or one dose of monovalent varicella vaccine: Results from five East European countries
Under a Creative Commons license
open access
Keywords
Children
Efficacy
Long-term follow-up
Live-attenuated varicella vaccine
Varicella zoster virus
Measles-mumps-rubella
Abbreviations
AEs
adverse events
ATP
according to protocol
CI
confidence interval
ELISA
enzyme-linked immunosorbent assay
GMC
geometric mean concentrations
HR
hazard ratio
HZ
herpes zoster
IDMC
independent data monitoring committee
IU
international units
MMRV
measles-mumps-rubella-varicella
PCR
polymerase chain reaction
SAEs
serious adverse events
TVC
total vaccinated cohort
V
monovalent varicella vaccine
VE
vaccine efficacy
VZV
varicella zoster virus
Cited by (0)
© 2021 GlaxoSmithKline Biologicals SA. Published by Elsevier Ltd.